Table 1.
Subject characteristics
Characteristics | Data |
---|---|
Total, no. | 17 |
No. men/no. women | 9/8 |
Median age, y (range) | 68 (49-88) |
Rai stage, no. | |
0 | 5 |
1 | 5 |
2 | 3 |
3 | 3 |
4 | 1 |
Prior therapy, no. | |
None | 11 |
Chlorambucil | 2 |
Chlorambucil, rituximab | 3 |
Cyclophosphamide, prednisone, rituximab | 1 |
Median absolute lymphocyte count × 109/L (range) | 32.5 (1.8-224.4) |
CD38−, no. | 16 |
CD38+, no. | 1 |
Interphase cytogenetics, FISH, no. | |
del 13q14 | 3 |
del 13q14, +12 | 1 |
del 13q14, ATM | 1 |
p53 | 1 |
No abnormalities | 2 |
Not available | 9 |